We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Genexine

News List

I-Mab, Kalbe Genexine Enter Strategic Pact contractpharma
April 01, 2020
KG Bio will have option for exclusive rights to commercialize two I-Mab product candidates.
PharmaJet unites with Genexine to develop DNA vaccine biospectrumasia
February 26, 2018
DNA vaccines can be used as targeted therapeutic vaccines to induce an immune response which can detect and destroy infectious diseases and potentially cancer
I-Mab Biopharma Signs Licensing Agreement for HyLeukin With Genexine prnasia
December 26, 2017
Genexine to receive an upfront payment and entitled to tiered, single-digit royalties on net sales of HyLeukin plus milestone payments from I-Mab Biopharma (I-Mab).